Table 3.
Variant | Signalling activity | Expression | Patients | Controls | References | ||
---|---|---|---|---|---|---|---|
n | Frequency (%) | n | Frequency (%) | ||||
p.Thr112Thr | NS | NS | 103 a | 3 | 268 | 0 | (3) |
p.Ser450Phe | ⇊ | = | 0 | ||||
p.Pro483Ser | ⇊ | = | 0 | ||||
p.Val102Ile | ↓ | NS | 69 | 3 | 100 | 2 | (23) |
p.Ser107Leu | = | NS | 1 | ||||
p.Ser107Leu | = | NS | 156 | 2 | 400 | 0 | Present study |
p.Arg448Trp | ↓ | NS | 0 | ||||
p.Pro772Ser | = | NS | 1.25 |
NS, not studied; =, similar to the WT.
Patients with CPHD and/or SOD.